Hi, what are you looking for?
La idea de la microdosificación de drogas psicodélicas ha existido durante mucho tiempo. Pero gracias a las tendencias entre las startups tecnológicas de alto...
"Breakthrough Therapy" designation is reserved for new therapies that have shown promise in preliminary research as a treatment for serious medical conditions.
While psilocybin is a controlled Schedule I substance, the FDA is allowing the University of Texas Health Science Center at Houston to test it...
30 terminal patients in St. Vincent's Hospital in Melbourne will receive synthetic psilocybin in a controversial trial.
Researchers tracked hundreds of psychedelics users and found that positive experiences led to improved psychological well-being.
Subscribe for exclusive access to deals, free giveaways and more!
Thank you for subscribing.
Something went wrong.